Last reviewed · How we verify
NCT06596239
Evaluating the Effectiveness of the Lower-Clear-Plate-Based Intermaxillary Traction
NA trial testing lower-clear-plate-based intermaxillary traction (LCP-IMT) in Class III Malocclusion in 30 participants. Completed in 15 June 2024.
15 March 2024
Quick facts
| Lead sponsor | Damascus University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 June 2023 |
| Primary completion | 15 March 2024 |
| Estimated completion | 15 June 2024 |
| Sites | 1 location across Syria |
Drugs / interventions tested
- lower-clear-plate-based intermaxillary traction (LCP-IMT)
- Removable mandibular retractor (RMR)
Conditions studied
- Class III Malocclusion — all drugs for Class III Malocclusion →
Sponsor
Damascus University
Who can join
Adults 9 to 13, any sex, with Class III Malocclusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients at the Orthodontic Department of the University of Damascus Dental School will be examined, and subjects who meet the inclusion criteria will be included. Then, initial diagnostic records (diagnostic gypsum models, internal and external oral photographs, and radiographic images) will be studied to ensure the selection criteria are accurately matched. This study compares two groups of patients with mild to moderate skeletal Class III in the late mixed occlusion stage. Experimental group: the patients in this group will be treated with Lower-Clear-Plate Based Intermaxillary Traction Control group: the patients in this group will be treated using the Removable Mandibular Retractor (RMR).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hard- and soft-tissue changes following the treatment of growing patients with skeletal class III malocclusion using the lower-clear-plate based intermaxillary traction versus the removable mandibular retractor: a two-arm randomized controlled trial.
Kheshfeh MN, Nassar N, Hajeer MY, Aljabban O, et al · · 2025 · PMID 41350990 · DOI 10.1186/s12903-025-07474-1
Verify or expand the search:
- PubMed search for NCT06596239
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Class III Malocclusion
Currently open trials in the same condition.
- NCT07162753 — Assesment of Ethnic Bias in an Artificial Intelligence Based Orthodontic Diagnosis System · recruiting
Other Damascus University trials
Trials by the same sponsor.
- NCT07532161 — Comparison Between Liquid Fibrin and Soft Laser Effects on Healing and Relapse After Lip Repositioning Surgery · NA · not yet recruiting
- NCT07515612 — The Impact of Valerian and Chamomile on Children's Anxiety in the Dental Clinic. · NA · recruiting
- NCT07272798 — Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension · recruiting
- NCT07426523 — Effectiveness of Needle-Free Infiltration Anesthesia in Reduction of Dental Pain and Anxiety During Local Anesthesia. · NA · completed
- NCT07366788 — Clinical Outcomes of Mandibular Primary Molar Extraction Using Physics Forceps in Children · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06596239 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Damascus University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06596239.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing